Medicine Box Chemist Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 27.00%
- Profit Growth -34.01%
- Ebitda 27.20%
- Net Worth -222.86%
- Total Assets -24.56%
About Medicine Box Chemist
Medicine Box Chemist Private Limited (MBCPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 January 2015 and has a history of Ten years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mausami Mehta, Anil Shukla, and Kamlesh Jain serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74120MH2015PTC261122
-
Company No.
261122
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Jan 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Medicine Box Chemist?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamlesh Jain
|
Director | 19-Jan-2015 | Current |
|
Mausami Mehta
|
Director | 14-Mar-2015 | Current |
|
Anil Shukla
|
Director | 14-Mar-2015 | Current |
Financial Performance of Medicine Box Chemist.
Medicine Box Chemist Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27% increase. The company also saw a substantial fall in profitability, with a 34.01% decrease in profit. The company's net worth observed a substantial decline by a decrease of 222.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicine Box Chemist?
In 2020, Medicine Box Chemist had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Oceanic Techno Chem Private LimitedKamlesh Jain is a mutual person
-
Oceanic Medi-Treat Private Limited
Kamlesh Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medicine Box Chemist?
Unlock and access historical data on people associated with Medicine Box Chemist, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicine Box Chemist, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicine Box Chemist's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
